| |
| |
|
| Insider
Information: |
Harris Todd |
| Relationship: |
|
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,075,568 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,075,568 |
|
|
| Total
Value |
$1 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sienna Biopharmaceuticals, Inc. |
SNNA |
|
2018-04-30 |
570,991 |
|
0 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
|
2024-03-15 |
1,504,577 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate DevelopmentO |
• • – |
2017-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
632,066 |
|
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-03-07 |
4 |
AS |
$20.00 |
$74,080 |
D/D |
(3,704) |
628,362 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-03-08 |
4 |
AS |
$20.03 |
$291,097 |
D/D |
(14,530) |
613,832 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-03-09 |
4 |
AS |
$20.01 |
$48,784 |
D/D |
(2,438) |
611,394 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-03-12 |
4 |
AS |
$20.11 |
$69,429 |
D/D |
(3,452) |
607,942 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-03-19 |
4 |
AS |
$20.00 |
$117,520 |
D/D |
(5,876) |
602,066 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-05 |
4 |
AS |
$20.00 |
$107,725 |
D/D |
(5,386) |
596,680 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-09 |
4 |
AS |
$20.00 |
$56,480 |
D/D |
(2,824) |
593,856 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-10 |
4 |
AS |
$20.02 |
$75,641 |
D/D |
(3,779) |
590,077 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-17 |
4 |
AS |
$20.00 |
$44,020 |
D/D |
(2,201) |
587,876 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-18 |
4 |
AS |
$20.09 |
$317,599 |
D/D |
(15,810) |
572,066 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-23 |
4 |
AS |
$20.00 |
$10,500 |
D/D |
(525) |
571,541 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-24 |
4 |
AS |
$20.00 |
$3,000 |
D/D |
(150) |
571,391 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-25 |
4 |
AS |
$20.00 |
$6,000 |
D/D |
(300) |
571,091 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Head of Corporate Development |
• • – |
2018-04-30 |
4 |
AS |
$20.00 |
$2,000 |
D/D |
(100) |
570,991 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive OfficerOfficer |
• • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,662,336 |
|
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
34,007 |
1,696,343 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
A |
$8.53 |
$26,642 |
D/D |
3,125 |
1,699,468 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$6.58 |
$11,895 |
D/D |
1,808 |
1,701,276 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-21 |
4 |
OE |
$2.25 |
$27,884 |
D/D |
12,393 |
1,713,669 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-21 |
4 |
AS |
$16.00 |
$198,288 |
D/D |
(12,393) |
1,701,276 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-22 |
4 |
AS |
$16.00 |
$64,688 |
D/D |
(4,043) |
1,701,276 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-22 |
4 |
OE |
$2.25 |
$9,097 |
D/D |
4,043 |
1,705,319 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-23 |
4 |
AS |
$16.00 |
$44,800 |
D/D |
(2,800) |
1,701,276 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Executive Officer |
• • – |
2023-03-23 |
4 |
OE |
$2.25 |
$6,300 |
D/D |
2,800 |
1,704,076 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
